The Mycophenolate Pregnancy Registry

Trial Profile

The Mycophenolate Pregnancy Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary)
  • Indications Asthma; Autoimmune disorders; Bone marrow transplant rejection; Heart transplant rejection; HIV infections; Kidney-pancreas transplant rejection; Liver transplant rejection; Lupus nephritis; Multiple sclerosis; Myasthenia gravis; Pemphigus; Respiratory syncytial virus infections; Rheumatoid arthritis; Systemic lupus erythematosus; Uveitis
  • Focus Adverse reactions
  • Sponsors Genentech
  • Most Recent Events

    • 01 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2021.
    • 01 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2021.
    • 01 Oct 2015 Planned End Date changed from 1 Nov 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top